Electronic Communications and Home Blood Pressure Monitoring
Completed · Phase 3
Conditions studied: Hypertension
In brief
The control of blood pressure (BP) for patients with hypertension on medications has been elusive, despite the availability of evidence-based nationally recognized guidelines for treatment and 30 years of research addressing this. At present, less than 50% of patients with known hypertension are adequately controlled. If BP control could be improved, significant decreases in cardiovascular morbidity and mortality would occur. The purpose of this study is to conduct a randomized controlled trial of the effectiveness of the provision of home blood pressure measurement and electronic communications (secure messaging to health care providers) to improve hypertension control.
Key facts
- Study ID
- NCT00158639
- Run by
- Kaiser Permanente
- People needed
- 778
- Starts
- 2005-06-01
- Expected to finish
- 2007-12-01
- Last updated by the study team
- 2017-10-13
Who can join
Age: 25 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of hypertension in the prior two years and on hypertension medications
- Access to the Internet and an e-mail address
- Ability to use a computer using the English language
- Medical care coverage which permits them to refill prescriptions at Group Health Cooperative pharmacies and a willingness to do so.
- Blood pressure on each of two screening visits averaging > 90 mmHg diastolic or > 140 mmHg systolic and < 110 mmHg diastolic or < 200 mmHg systolic
You may not qualify if…
- Diagnosed or history of diabetes, cardiovascular disease (ischemic heart disease, valvular heart disease, heart failure, arrhythmias, strokes or transient ischemic attacks, and peripheral vascular disease)
- Current treatment for cancer, on immunosuppressant or antiretroviral treatment.
- Surgery or hospitalization in the prior 3 months
- Pregnancy (or plans to become pregnant in the next 12 months)
- Plans to move out of the area or leave the health plan in the next 12 months.
- Upper arm circumference size > 18 inches.
- Arrhythmia detected at screening visits
Where it is running
- Group Health Research Institute — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.